YOLFTbeta
30

Zhejiang Tianyu Pharmaceutical Co Ltd

300702 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

20.18CNY-0.42 (-2.04%)

Price History

Full chart

Market Stats

Previous Close20.60
Open20.56
Day Range20.15 – 20.75
52-Week Range17.98 – 27.73
Volume1.74M
Market Cap7.89B
P/E (TTM)84.00
Forward P/E0.00
EPS0.27
Dividend Yield0.22%
Beta0.25
50-Day Avg21.32
200-Day Avg22.19

About

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-allergic, anticancer, anti-fungal, anti-epileptic, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It also provides fine chemicals and CDMO services. The company was founded in 1993 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yong Jun Tu
  • Employees4.69K
  • HeadquartersHuangyan Jiangkou Chemical Dev Zn, Taizhou, China, 318020, China
  • Websitehttps://www.tianyupharm.com

Leadership

  • Mr. Yong Jun TuChairman & GM · b. 1963
  • Mr. Guo Rong ZhuDeputy GM & Non-Independent Director · b. 1975
  • Mr. Chuanliang DengDeputy GM & Non-Independent Director · b. 1974
  • Mr. Fujun WangDeputy General Manager · b. 1973
  • Ms. Yan WangBoard Secretary & Deputy GM · b. 1980
  • Ms. Chong WangCFO & Accounting Supervisor · b. 1982

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue723.25M777.35M840.09M1.08B1.19B1.47B2.11B2.59B2.55B2.67B2.53B2.63B3.06B
Growth (%)-+7.48%+8.07%+28.84%+9.79%+23.45%+43.88%+22.59%-1.64%+4.78%-5.23%+4.10%+16.36%
Cost of Revenue527.75M563.20M571.84M687.06M754.01M894.75M976.76M1.30B1.64B2.08B1.68B1.76B1.93B
Gross Profit195.50M214.15M268.24M395.27M434.27M572.21M1.13B1.29B907.42M591.07M849.83M869.86M1.14B
Gross Margin27.03%27.55%31.93%36.52%36.55%39.01%53.72%49.87%35.65%22.17%33.63%33.06%37.09%
Operating Expense154.61M187.60M212.29M257.49M314.39M376.45M445.53M514.67M667.34M692.91M779.08M784.98M831.08M
Operating Income40.89M26.55M55.95M137.79M119.89M195.75M688.31M775.75M240.08M-101.83M70.75M84.87M304.40M
Operating Margin5.65%3.42%6.66%12.73%10.09%13.34%32.61%29.98%9.43%-3.82%2.80%3.23%9.94%
EBITDA51.92M59.58M82.18M211.57M232.76M298.33M777.66M855.50M371.04M164.56M439.74M432.50M559.79M
EBITDA Margin7.18%7.66%9.78%19.55%19.59%20.34%36.85%33.06%14.58%6.17%17.40%16.44%18.29%
Net Income33.59M24.14M50.35M122.34M100.18M163.66M585.73M667.06M204.68M-118.87M27.36M55.94M139.71M
Net Income Margin4.64%3.11%5.99%11.30%8.43%11.16%27.75%25.78%8.04%-4.46%1.08%2.13%4.56%
R&D32.74M31.08M41.41M58.73M59.21M79.46M112.25M179.07M227.40M231.10M243.82M247.23M240.31M
R&D as % of Total Revenue4.53%4.00%4.93%5.43%4.98%5.42%5.32%6.92%8.94%8.67%9.65%9.40%7.85%
Interest Expense22.60M22.26M25.77M23.68M24.86M20.57M13.23M5.59M17.45M35.12M51.24M55.97M43.13M
Interest Expense % of Total Revenue3.12%2.86%3.07%2.19%2.09%1.40%0.63%0.22%0.69%1.32%2.03%2.13%1.41%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets971.79M1.08B1.33B1.52B2.11B2.63B2.84B4.89B5.80B6.42B6.34B6.58B6.59B
Total Liabilities518.11M628.67M830.58M907.72M818.99M1.18B803.09M1.34B2.09B2.92B2.85B3.08B2.95B
Total Equity453.68M456.22M495.77M607.31M1.29B1.45B2.04B3.55B3.71B3.50B3.49B3.50B3.64B
Cash109.96M96.45M145.21M179.96M220.03M346.31M142.10M1.30B476.75M476.98M426.15M592.87M512.25M
Total Debt334.55M321.65M409.83M486.52M337.90M484.17M53.85M264.43M637.26M1.29B1.74B1.74B-
Net Debt224.59M225.20M264.62M306.56M117.87M137.86M-88.25M-1.03B160.51M810.23M1.31B1.15B1.12B

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow39.73M80.44M14.75M164.74M88.52M78.57M427.84M622.18M-262.23M-48.70M-43.90M344.64M473.57M
Investing Cash Flow-66.24M-71.63M-57.15M-133.82M-452.10M-91.47M-159.69M-517.30M-802.37M-520.82M-355.35M-217.30M-
Financing Cash Flow20.35M-62.94M62.86M-24.67M429.49M142.67M-468.74M1.01B229.67M519.34M363.35M22.85M-
Capital Expenditure68.31M79.99M62.59M107.44M112.54M179.89M354.10M506.05M736.39M527.01M316.81M168.95M357.77M
Free Cash Flow-28.58M452.79K-47.84M57.30M-24.02M-101.32M73.73M116.13M-998.62M-575.71M-360.71M175.69M115.80M
Dividends Paid40.36M38.79M25.07M45.62M53.60M36.61M27.33M91.10M96.66M34.80M51.12M70.19M57.96M
FCF to OCF-71.94%0.56%-324.28%34.78%-27.14%-128.95%17.23%18.66%380.82%1182.16%821.57%50.98%24.45%
Dividend Paid to FCF-141.22%8566.63%-52.40%79.61%-223.13%-36.13%37.07%78.45%-9.68%-6.04%-14.17%39.95%50.05%

Earnings

Report DateOct 28, 2017Dec 31, 2017Apr 26, 2018Aug 30, 2018Oct 31, 2018Feb 25, 2019Apr 23, 2019Aug 21, 2019Oct 24, 2019Feb 28, 2020Apr 23, 2020Aug 24, 2020Oct 22, 2020Dec 31, 2020Apr 19, 2021Aug 26, 2021Oct 21, 2021Dec 31, 2021Apr 21, 2022Aug 29, 2022Oct 25, 2022Apr 26, 2023Aug 28, 2023Oct 19, 2023Apr 25, 2024Aug 29, 2024Oct 28, 2024Apr 24, 2025Aug 25, 2025Oct 30, 2025Apr 27, 2026Aug 28, 2026
EPS Estimate--------------------0.59-----------
EPS Actual0.10-0.020.060.060.120.260.380.390.580.430.510.660.600.270.680.140.07-0.000.240.03-0.16-0.46-0.090.000.120.040.090.250.180.210.120.18
Surprise---------------------127.12%-----------
TimingAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap7.89B
Enterprise Value8.76B
Trailing P/E84.00
Forward P/E0.00
Price / Sales2.39
Price / Book2.10
EPS0.27
Book Value10.33
Revenue (TTM)3.30B
Gross Profit (TTM)1.07B
EBITDA542.82M
Profit Margin2.75%
Operating Margin6.33%
Return on Equity2.37%
Return on Assets1.68%
Shares Outstanding347.98M
Shares Float159.05M
Beta0.25
Dividend Yield0.22%
Dividend Rate0.05
Payout Ratio9.85%

Dividends

20261×
0.05Jun 2, 2026
20251×
0.05Jun 6, 2025
20241×
0.05Jun 6, 2024
20221×
0.10Jun 13, 2022
20211×
0.28Jun 18, 2021
20201×
0.28Jun 24, 2020
20191×
0.08May 24, 2019
20181×
0.05Jun 12, 2018

Stock Splits

  • Jun 18, 20211.8:1
  • Jun 12, 20181.4917:1